Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multi-Omic Biomarkers as Potential Tools for the Characterisation of Pancreatic Cystic Lesions and Cancer: Innovative Patient Data Integration
Laura Kane, Gregory S. Mellotte, Kevin C. Conlon, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 769-769
Open Access | Times Cited: 19

Showing 19 citing articles:

Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis
Laura Kane, Gregory S. Mellotte, Eimear Mylod, et al.
Cancer Research Communications (2022) Vol. 2, Iss. 10, pp. 1229-1243
Open Access | Times Cited: 27
Development of a blood-based extracellular vesicle classifier for detection of early-stage pancreatic ductal adenocarcinoma
Juan Pablo Hinestrosa, Rosalie C. Sears, Harmeet Dhani, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 13
Recent Progress in Enhanced Cancer Diagnosis, Prognosis, and Monitoring Using a Combined Analysis of the Number of Circulating Tumor Cells (CTCs) and Other Clinical Parameters
Thi Nguyen, Po-Shuan Huang, Po-Yu Chu, et al.
Cancers (2023) Vol. 15, Iss. 22, pp. 5372-5372
Open Access | Times Cited: 12
Multi-omic biomarker panel in pancreatic cyst fluid and serum predicts patients at a high risk of pancreatic cancer development
Laura Kane, Gregory S. Mellotte, Eimear Mylod, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Molecular insights into pancreatic cysts: navigating diagnosis and precision management
Rudy El Asmar, N. Bizri, Nikhil V Tirukkovalur, et al.
(2025) Vol. 4
Open Access
The Integration of Metabolomics with Other Omics: Insights into Understanding Prostate Cancer
Eleazer P. Resurreccion, Ka-wing Fong
Metabolites (2022) Vol. 12, Iss. 6, pp. 488-488
Open Access | Times Cited: 17
Pancreatic Incidentaloma
M Caban, Ewa Małecka‐Panas
Journal of Clinical Medicine (2022) Vol. 11, Iss. 16, pp. 4648-4648
Open Access | Times Cited: 12
DDX21 functions as a potential novel oncopromoter in pancreatic ductal adenocarcinoma: a comprehensive analysis of the DExD box family
Shaohan Wu, Xiaofang Sun, Ruheng Hua, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Pancreatic Cancer Health Disparity: Pharmacologic Anthropology
Nathan R. Wall, Ryan N. Fuller, Ann Morcos, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5070-5070
Open Access | Times Cited: 6
Clustering analysis revealed the autophagy classification and potential autophagy regulators' sensitivity of pancreatic cancer based on multi‐omics data
Yonghao Chen, Jialin Meng, Xiaofan Lu, et al.
Cancer Medicine (2022) Vol. 12, Iss. 1, pp. 733-746
Open Access | Times Cited: 9
Case Report: Early detection of pancreatic pre-cancer lesion in multimodal approach with exosome liquid biopsy
Harmeet Dhani, Juan Pablo Hinestrosa, Jesus Izaguirre-Carbonell, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Oncogenic KRAS-Induced Protein Signature in the Tumor Secretome Identifies Laminin-C2 and Pentraxin-3 as Useful Biomarkers for the Early Diagnosis of Pancreatic Cancer
Mohammad Azhar Kamal, Imran Siddiqui, Cristina Belgiovine, et al.
Cancers (2022) Vol. 14, Iss. 11, pp. 2653-2653
Open Access | Times Cited: 7
Electrochemical immunoplatform to help managing pancreatic cancer
Víctor Pérez‐Ginés, Rebeca M. Torrente‐Rodríguez, Marı́a Pedrero, et al.
Journal of Electroanalytical Chemistry (2023) Vol. 935, pp. 117312-117312
Open Access | Times Cited: 3
Cytogenetics to multiomics in biology of cancer
Sikander Gill, Rajwant K. Gill, R. C. Sobti
Elsevier eBooks (2024), pp. 151-186
Closed Access
Novel Insights into Postoperative Surveillance in Resected Pancreatic Cystic Neoplasms—A Review
Daniel Vasile Balaban, Laura-Ioana Coman, Marina Balaban, et al.
Diagnostics (2024) Vol. 14, Iss. 10, pp. 1056-1056
Open Access
Integrating OMICS-based platforms and analytical tools for diagnosis and management of pancreatic cancer: a review
Patrícia Sousa, Laurentina Silva, José S. Câmara, et al.
Molecular Omics (2024)
Closed Access
SAMHD1 as a prognostic and predictive biomarker in stage II colorectal cancer: A multicenter cohort study
Dingyun You, Shuai Zhang, Shan Yan, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 2
Data from Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis
Laura Kane, Gregory S. Mellotte, Eimear Mylod, et al.
(2023)
Open Access
Pancreatic Cystic Neoplasms: Serous Cystadenoma, Mucinous Cystadenoma
Inmaculada Sánchez-Matamoros Martín, Juan Antonio Bellido Luque, Juan Manuel Castillo Tuñón, et al.
Springer eBooks (2023), pp. 13-21
Closed Access
Page 1

Scroll to top